Salirasib
Salirasib is a Ras inhibitor that inhibits specifically both oncogenically activated Ras and growth factor receptor-mediated Ras activation, resulting in the inhibition of Ras-dependent tumor growth.
Product Specifications
Product Name Alternative
S-Farnesylthiosalicylic acid; Farnesyl Thiosalicylic Acid; FTS
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Autophagy; Ras
Type
Reference compound
Related Pathways
Autophagy; GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Salirasib.html
Purity
99.04
Solubility
DMSO : ≥ 50 mg/mL
Smiles
O=C(O)C1=CC=CC=C1SC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C
Molecular Formula
C22H30O2S
Molecular Weight
358.54
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14754/Salirasib-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14754/Salirasib-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
Phase 2
CAS Number
[162520-00-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Rho Guanine Nucleotide Exchange Factor 26 / SGEF (ARHGEF26) Antibody
Rho Guanine Nucleotide Exchange Factor 26 / SGEF (ARHGEF26) Antibody
